Nutritional supplementation with trans-10, cis-12-conjugated linoleic acid induces inflammation of white adipose tissue

Diabetes

Volumn 55, Issue 6, 2006, Pages 1634-1641

  Poirier, Hélène ^a   Shapiro, Jennifer S ^b   Kim, Roy J ^b   Lazar, Mitchell A ^b  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

c9,t11 CLA, cis 9,trans 11 isomer of conjugated linoleic acid; CLA, conjugated linoleic acid; DMEM, Dulbecco's modified Eagle's medium; FBS, fetal bovine serum; IL 6, interleukin 6; IR , insulin receptor ; IRS 1, insulin receptor substrate 1

Indexed keywords

ADIPONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 6; LEPTIN; LINOLEIC ACID; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONJUGATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; FATTY LIVER; FEMALE; GLUCOSE TRANSPORT; HYPERINSULINEMIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULIN RESISTANCE; ISOMER; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; WEIGHT REDUCTION;

3T3-L1 CELLS; ADIPONECTIN; ADIPOSE TISSUE, WHITE; ANIMALS; DIETARY SUPPLEMENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HYPERINSULINISM; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-6; LEPTIN; LINOLEIC ACIDS, CONJUGATED; MACROPHAGES; MICE; MICE, INBRED C57BL; NF-KAPPA B; PPAR GAMMA; RESISTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748291462     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0036     Document Type: Article

References (43)

1. Haslam DW, James WP: Obesity. Lancet 366:1197-1209, 2005
2. Turpeinen AM, Mutanen M, Aro A, Salminen I, Basu S, Palmquist DL, Griinari JM: Bioconversion of vaccenic acid to conjugated linoleic acid in humans. Am J Clin Nutr 76:504-510, 2002
3. Wang YW, Jones PJ: Conjugated linoleic acid and obesity control: efficacy and mechanisms. Int J Obes Relat Metab Disord 28:941-955, 2004
4. Park Y, Albright KJ, Liu W, Storkson JM, Cook ME, Pariza MW: Effect of conjugated linoleic acid on body composition in mice. Lipids 32:853-858, 1997
5. West DB, Delany JP, Camet PM, Blohm F, Truett AA, Scimeca J: Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am J Physiol 275:R667-R672, 1998
6. DeLany JP, Blohm F, Truett AA, Scimeca JA, West DB: Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. Am J Physiol 276:R1172-R1179, 1999
7. Tsuboyama-Kasaoka N, Takahashi M, Tanemura K, Kim HJ, Tange T, Okuyama H, Kasai M, Ikemoto S, Ezaki O: Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49:1534-1542, 2000
8. Clement L, Poirier H, Niot I, Bocher V, Guerre-Millo M, Krief S, Staels B, Besnard P: Dietary trans-10,cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J Lipid Res 43:1400-1409, 2002
9. Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O: Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr 130:2943-2948, 2000
10. Thom E, Wadstein J, Gudmundsen O: Conjugated linoleic acid reduces body fat in healthy exercising humans. J Int Med Res 29:392-396, 2001
11. Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O: Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr 135:778-784, 2005
12. Riserus U, Arner P, Brismar K, Vessby B: Treatment with dietary trans10,cis12-conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 25:1516-1521, 2002
13. Riserus U, Smedman A, Basu S, Vessby B: Metabolic effects of conjugated linoleic acid in humans: the Swedish experience. Am J Clin Nutr 79:1146S-1148S, 2004
14. Moloney F, Yeow TP, Mullen A, Nolan JJ, Roche HM: Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr 80:887-895, 2004
15. Nawrocki AR, Scherer PE: Keynote review: the adipocyte as a drug discovery target. Drug Discov Today 10:1219-1230, 2005
16. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830, 2003
17. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808, 2003
18. Reitman ML, Arioglu E, Gavrilova O, Taylor SI: Lipoatrophy revisited. Trends Endocrinol Metab 11:410-416, 2000
19. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946, 2001
20. Shimomura I, Hammer RE, Ikemoto S, Brown MS, Goldstein JL: Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401:73-76, 1999
21. Javor ED, Cochran EK, Musso C, Young JR, Depaoli AM, Gorden P: Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes 54:1994-2002, 2005
22. Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, DePaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A: Leptin-replacement therapy for lipodystrophy. N Engl J Med 346:570-578, 2002
23. House RL, Cassady JP, Eisen EJ, Eling TE, Collins JB, Grissom SF, Odle J: Functional genomic characterization of delipidation elicited by trans-10, cis-12-conjugated linoleic acid (t10c12-CLA) in a polygenic obese line of mice. Physiol Genomics 21:351-361, 2005
24. Rangwala SM, Rhoades B, Shapiro JS, Rich AS, Kim JK, Shulman GI, Kaestner KH, Lazar MA: Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity. Dev Cell 5:657-663, 2003
25. Rajala MW, Qi Y, Patel HR, Takahashi N, Banerjee R, Pajvani UB, Sinha MK, Gingerich RL, Scherer PE, Ahima RS: Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 53:1671-1679, 2004
26. Kolb H, Mandrup-Poulsen T: An immune origin of type 2 diabetes? Diabetologia 48:1038-1050, 2005
27. Pirola L, Johnston AM, Van Obberghen E: Modulation of insulin action. Diabetologia 47:170-184, 2004
28. Miner JL, Cederberg CA, Nielsen MK, Chen X, Baile CA: Conjugated linoleic acid (CLA), body fat, and apoptosis. Obes Res 9:129-134, 2001
29. Hargrave KM, Li C, Meyer BJ, Kachman SD, Hartzell DL, Della-Fera MA, Miner JL, Baile CA: Adipose depletion and apoptosis induced by trans-10, cis-12 conjugated linoleic acid in mice. Obes Res 10:1284-1290, 2002
30. Hammarstedt A, Andersson CX, Rotter Sopasakis V, Smith U: The effect of PPARgamma ligands on the adipose tissue in insulin resistance. Prostaglandins Leukot Essent Fatty Acids 73:65-75, 2005
31. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 100:2777-2782, 1997
32. Fasshauer M, Klein J, Kralisch S, Klier M, Lossner U, Bluher M, Paschke R: Serum amyloid A3 expression is stimulated by dexamethasone and interleukin-6 in 3T3-L1 adipocytes. J Endocrinol 183:561-567, 2004
33. Fasshauer M, Klein J, Lossner U, Paschke R: Interleukin (IL)-6 mRNA expression is stimulated by insulin, isoproterenol, tumour necrosis factor alpha, growth hormone, and IL-6 in 3T3-L1 adipocytes. Horm Metab Res 35:147-152, 2003
34. Poirier H, Rouault C, Clement L, Niot I, Monnot MC, Guerre-Millo M, Besnard P: Hyperinsulinaemia triggered by dietary conjugated linoleic acid is associated with a decrease in leptin and adiponectin plasma levels and pancreatic beta cell hyperplasia in the mouse. Diabetologia 48:1059-1065, 2005
35. Chung S, Brown JM, Provo JN, Hopkins R, McIntosh MK: Conjugated linoleic acid promotes human adipocyte insulin resistance through NF{kappa}B-dependent cytokine production. J Biol Chem 280:38445-38456, 2005
36. Brown JM, Boysen MS, Chung S, Fabiyi O, Morrison RF, Mandrup S, McIntosh MK: Conjugated linoleic acid induces human adipocyte delipidation: autocrine/paracrine regulation of MEK/ERK signaling by adipocytokines. J Biol Chem, 279:26735-26747, 2004
37. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, Paschke R: Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes. J Endocrinol 181:129-138, 2004
38. Dahlman I, Kaaman M, Olsson T, Tan GD, Bickerton AS, Wahlen K, Andersson J, Nordstrom EA, Blomqvist L, Sjogren A, Forsgren M, Attersand A, Arner P: A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab 90:5834-5840, 2005
39. Jan V, Cervera P, Maachi M, Baudrimont M, Kim M, Vidal H, Girard PM, Levan P, Rozenbaum W, Lombes A, Capeau J, Bastard JP: Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients. Antivir Ther 9:555-564, 2004
40. Kamin D, Hadigan C, Lehrke M, Mazza S, Lazar MA, Grinspoon S: Resistin levels in human immunodeficiency virus-infected patients with lipoatrophy decrease in response to rosiglitazone. J Clin Endocrinol Metab 90:3423-3426, 2005
41. Pajvani UB, Trujillo ME, Combs TP, Iyengar P, Jelicks L, Roth KA, Kitsis RN, Scherer PE: Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nat Med 11:797-803, 2005
42. Evans M, Geigerman C, Cook J, Curtis L, Kuebler B, McIntosh M: Conjugated linoleic acid suppresses triglyceride accumulation and induces apoptosis in 3T3-L1 preadipocytes. Lipids 35:899-910, 2000
43. Riserus U, Vessby B, Arner P, Zethelius B: Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity. Diabetologia 47:1016-1019, 2004